SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: RockDoc who wrote (448)2/3/1999 4:27:00 PM
From: Rick Strange  Respond to of 1386
 
You'r right about tamoxifen being an analog of a blockbuster drug. LE-T is an extension of Lotemax into an additional sizable established market. HU211 is the jewel in the crown and this is a case of a "path not taken" by others, that PARS took. I don't know if there is just one best approach. Ariella, I hope I didn't sound critical when I tried to answer your questions.